Skip to main content
. 2015 Sep 14;11(9):e1005162. doi: 10.1371/journal.ppat.1005162

Table 5. Oligonucleotides used in this study.

Primer Sequence* Enz.
pglHNF2 GTCGACGGAATTTCATTTCCGGAAAAC SalI
pglHNR GGATCCAGCAATAAGGGGCGACGATG BamHI
pglHCF GGATCCAAGTTGCCGAAGTCCTTAC BamHI
pglHCR GAGCTCACCGCCAGATTGAAAATGC SacI
E707F GAGGCATTTCCTTTCCAATTAGGAGTAATTTTATGAAAGCAATCCAAAAAGGTTTC
E707R CCATTTATTATTTCCTTCCTCTTTTCTGATCCTTACTTATTTGGTGCGGCAGGTAGA
8013-lpxC-pilE_FWD GCCGTCTGAAGCGTCGGGCAAATCATCGC
8013-lpxC-pilE_REV GATTGTGATTGCCATCGTCG
FAM20-pilE_FWD gccgtctgaaATTTGGTGCGGCAGGTAG
FAM20-pilE_REV AGGTTTCACCCTGATCGAG
McPilRBS gcatttcctttccaattaggag
3-end-ErmR_FWD cgttatgaaatgggttaaca
Mid_pilEandS1FWD GTCAGCAGTGCCGAAAATTGTCAG
Late_pilEandS1FWD CCTCGTCGGTGCAGAAACTTA
3’end_pilS1 FWD ctcggtgacggctgatttttgac
5’END_FKBP REV gctgaaagtgtacgaataaAGC
3’END_PILS5 REV CTGACATAAtggcttcaag
3END8013REVPILS1 CATCCTTTTGGTCgaaggtc
3END8013FORPILS1 gaccttcGACCAAAAGGATG
3END8013REVPILS2 GACGAAGCTATCCTTttggccg
428BP_PRE-PILS1 FOR CATCGGTACGGAAACTTATCG
FAM18-PILE_FWD gccgtctgaaATTTGGTGCGGCAGGTAG
FAM18-PILE_REV AGGTTTCACCCTGATCGAG

* Restriction sites in bold